GSK 525762A-d5
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
GSK 525762A-d5 Product Information
GSK 525762A-d5 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with GSK 525762A. The product is supplied by Clearsynth under CAT No. CS-T-103436.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
GSK 525762A-d5
CAT No.
CS-T-103436
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C22H17D5ClN5O2
Molecular Weight
428.93
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
GSK 525762A-d5 is supplied with detailed characterization data compliant with regulatory guideline. GSK 525762A-d5 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of GSK 525762A.
Overview
GSK 525762A-d5, is the labeled analogue of GSK 525762A (G797505), which is a BET Bromodomain Inhibitor currently in clinical development. BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.
Synonyms
GSK 525762A-d5
Application Notes
GSK 525762A-d5, is the labeled analogue of GSK 525762A (G797505), which is a BET Bromodomain Inhibitor currently in clinical development. BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.